BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › Identification and validation of a multigene predictor of recurrence in primary laryngeal cancer.

Dataset: Identification and validation of a multigene predictor of recurrence in primary laryngeal cancer.

Background: Local recurrence is the major manifestation of treatment failure in patients with operable laryngeal carcinoma. Established...

Registered by ArrayExpress Uploader
View Dataset

Background: Local recurrence is the major manifestation of treatment failure in patients with operable laryngeal carcinoma. Established clinicopathological factors cannot sufficiently predict patients that are likely to recur after treatment. Additional tools are therefore required to accurately identify patients at high risk for recurrence. Methods: Using Affymetrix U133A Genechips, we profiled fresh-frozen tumor tissues from 59 patients with operable laryngeal cancer. All patients were treated locally with surgery, with or without radiation therapy. We performed Cox regression proportional hazards modeling to identify multigene predictors of recurrence. The end-point of our analysis was disease-free survival (DFS). Gene models were directly validated in a separate, similarly treated cohort of 50 patients using Affymetrix chips. In an attempt to further validate our results, we profiled 12 selected genes of our model in formalin-fixed tumor tissues from an independent cohort of 75 patients, using quantitative real time-polymerase chain reaction (qRT-PCR). Results: We focused on genes univariately associated with DFS (p<0.05) in the training set. Among several gene models comprising different numbers of genes, a 30-gene model demonstrated optimal performance (log-rank, p<0.001). We directly applied these gene models to the validation set, after adjusting for non-biological experimental variability, and observed similar results. Specifically, median DFS, as predicted by the 30-gene model, was 34 and 80 months for high- and low-risk patients, respectively (p=0.01). Hazard Ratio (HR) for recurrence for the high-risk group was 3.87 (95% CI 1.28-11.73, p=0.017). Furthermore, unsupervised hierarchical clustering of the 75 patients, based on the qRT-PCR 12-gene profile, yielded two groups, which differed significantly in DFS (log-rank, p=0.027). HR= for recurrence was 2.26, (95% CI 1.08-4.76, p=0.031). Conclusion: We have established and validated gene models that can successfully stratify patients with laryngeal cancer, based on their risk for recurrence. Thus, patients with unfavorable prognosis, when accurately identified, could be ideal candidates for the application of more aggressive treatment modalities. Training set comprises 59 samples and validation set 50 samples

Species:
human

Samples:
109

Source:
E-GEOD-27020

PubMed:
23950933

Updated:
Dec.12, 2014

Registered:
Jun.18, 2014


Factors: (via ArrayExpress)
Sample GRADE GROUP AGE DFS MONTHS DFS STATUS 1 = RECURRED
GSM665652 2 validation set 41 94 1
GSM66565 1 validation set 74 71 1
GSM665650 1 validation set 68 13 1
GSM665649 2 validation set 82 23 1
GSM665648 1 validation set 53 24 1
GSM665647 1 validation set 70 42 1
GSM665646 2 validation set 61 9 1
GSM665645 1 validation set 74 12 1
GSM665644 1 validation set 62 80 1
GSM665643 1 validation set 63 16 1
GSM665642 3 validation set 61 20 0
GSM66564 1 validation set 55 2 1
GSM665640 3 validation set 47 15 1
GSM665639 2 validation set 60 21 0
GSM665638 1 validation set 82 21 0
GSM665637 2 validation set 69 5 1
GSM665636 3 validation set 72 18 0
GSM665635 2 validation set 57 23 0
GSM665634 2 validation set 78 18 0
GSM665633 2 validation set 63 12 0
GSM665632 2 validation set 56 24 0
GSM66563 2 validation set 73 24 0
GSM665630 3 validation set 60 27 0
GSM665629 2 validation set 76 27 0
GSM665628 1 validation set 77 22 1
GSM665627 2 validation set 64 27 0
GSM665626 1 validation set 50 28 0
GSM665625 1 validation set 69 3 1
GSM665624 2 validation set 60 20 1
GSM665623 1 validation set 48 28 0
GSM665622 1 validation set 70 30 0
GSM66562 1 validation set 53 30 0
GSM665620 3 validation set 63 20 0
GSM665619 1 validation set 56 30 0
GSM665618 2 validation set 67 31 0
GSM665617 1 validation set 67 31 0
GSM665616 1 validation set 79 8 1
GSM665615 2 validation set 60 33 0
GSM665614 2 validation set 59 6 1
GSM665613 1 validation set 53 33 0
GSM665612 2 validation set 63 34 0
GSM6656 1 validation set 69 34 0
GSM665610 2 validation set 64 35 0
GSM665609 2 validation set 72 10 1
GSM665608 2 validation set 66 36 0
GSM665607 2 validation set 67 11 1
GSM665606 3 validation set 72 34 1
GSM665605 1 validation set 67 37 0
GSM665604 1 validation set 81 38 0
GSM665603 1 validation set 54 40 0
GSM665602 2 training set 67 41 0
GSM66560 3 training set 81 42 0
GSM665600 2 training set 68 13 1
GSM665599 1 training set 41 44 0
GSM665598 2 training set 62 42 0
GSM665597 1 training set 54 43 0
GSM665596 1 training set 49 43 0
GSM665595 2 training set 55 43 0
GSM665594 2 training set 80 45 0
GSM665593 2 training set 65 44 0
GSM665592 1 training set 66 46 0
GSM66559 2 training set 67 46 0
GSM665590 1 training set 49 47 0
GSM665589 3 training set 65 48 0
GSM665588 2 training set 64 8 1
GSM665587 2 training set 68 49 0
GSM665586 1 training set 79 50 0
GSM665585 2 training set 61 51 0
GSM665584 2 training set 69 52 0
GSM665583 2 training set 60 92 0
GSM665582 1 training set 60 50 1
GSM66558 2 training set 67 52 0
GSM665580 1 training set 68 54 0
GSM665579 1 training set 59 54 0
GSM665578 3 training set 61 14 1
GSM665577 1 training set 74 1 0
GSM665576 2 training set 71 37 0
GSM665575 2 training set 60 55 0
GSM665574 3 training set 74 56 0
GSM665573 2 training set 50 20 1
GSM665572 3 training set 55 42 0
GSM66557 3 training set 69 58 0
GSM665570 2 training set 55 13 1
GSM665569 3 training set 72 57 0
GSM665568 3 training set 70 41 0
GSM665567 1 training set 46 29 1
GSM665566 2 training set 58 36 0
GSM665565 2 training set 65 6 1
GSM665564 1 training set 49 61 0
GSM665563 2 training set 48 61 0
GSM665562 1 training set 50 62 0
GSM66556 1 training set 72 43 0
GSM665560 2 training set 74 46 0
GSM665559 2 training set 62 8 1
GSM665558 1 training set 51 62 0
GSM665557 2 training set 43 43 0
GSM665556 2 training set 45 64 0
GSM665555 not specified training set 68 63 0
GSM665554 2 training set 48 65 0
GSM665553 2 training set 64 64 0
GSM665552 2 training set 88 14 1
GSM66555 2 training set 82 65 0
GSM665550 1 training set 58 16 1
GSM665549 1 training set 70 64 0
GSM665548 3 training set 58 7 1
GSM665547 1 training set 57 68 0
GSM665546 3 training set 69 8 1
GSM665545 not specified training set 60 70 0
GSM665544 1 training set 54 45 0

Tags

  • cancer
  • carcinoma
  • disease
  • laryngeal carcinoma
  • median
  • point

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2025 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use